Exclusive: Indonesia’s Alodokter said to have closed $7m Series B backed by SoftBank

Photo: Alodokter's Facebook page

Golden Gate Ventures-backed Indonesian digital health startup Alodokter.com is learnt to have raised around $7 million in a Series B round. Japan’s SoftBank Group Corp was among the investors that participated in the round, according to three people aware of the development.

At the time of publishing this story, Alodokter had not responded to an email query from DEALSTREETASIA on the new funding round.

This portal had in June reported that Alodokter and its competitor Halodoc were in talks with “international players” to secure Series B round of funding.

Halodoc, whose series A round in 2017 was joined by ride-hailing giant Go-Jek, was said to be looking at raising over $15 million by early next year, while Alodokter was eyeing about $5-6 million.

In 2016, Alodokter had closed its $2.5 million Series A round led by Golden Gate Ventures, with participation from return backers 500 Startups and Singaporean entrepreneur Lim Dershing. All three investors had also participated in its seed round in April 2015.

Alodokter had then said it would use the proceeds to expand its business operations across Southeast Asia. It currently generates revenues from advertisements by healthcare-related brands on its portal and app.

Founded in 2014 by CEO Nathanael Faibis, Alodokter now boasts over 12 million monthly active users. It offers content about health, well-being and family. The startup launched the Alodokter app in March 2016 that claims to have over 150,000 users’ questions answered every month by doctors via a chat platform. Faibis had earlier said that Alodokter plans to launch a hospital comparison app soon.

Currently, Alodokter sees competition from local rivals Dokter.id, MeetDoctor, KlikDokter, and 1Health, apart from Halodoc.

Indonesia’s healthcare expenditure is expected to grow from $26 billion in 2014 to $51 billion by 2020, according to industry experts. The sector is currently dominated by out-of-pocket spending that constitutes about 75 per cent of total transactions. With such low insurance-covered expenditures, there is an opportunity for direct-to-consumer play to optimize the value chain in healthcare. Many international investors are excited at this opportunity, given that such problems could be solved through advances in technology.

Indonesia’s healthcare market is already seeing growing interest from global and local investors. In October last year, private equity firm Saratoga Capital entered the space with an investment in hospital operator FABS. Other healthtech firms have also expanded to Indonesia, including the Philippines’ mClinica, a platform connecting pharmacies and collecting healthcare data, and India’s fastest growing healthcare startup Practo.

Also Read:

Golden Gate to raise third fund within 2-3 years, a few B2C, fintech exits on the cards: Jeffrey Paine

Exclusive: Indonesian healthtech startups Alodokter, Halodoc eye next fundraise

Meaningful exit is primary need for Asean startup ecosystem: Justin Hall, GGV